| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Centre for Integrated Systems Biology and Medicine, School of Biomedical Sciences, Queens Medical Centre, University of Nottingham NG7 2UH, United Kingdom
Address all correspondence and requests for reprints to: Francis B. Stephens, E Floor, School of Biomedical Sciences, University of Nottingham Medical School, Queens Medical Centre, Nottingham NG7 2UH, United Kingdom. E-mail: francis.stephens{at}nottingham.ac.uk.
Context: Carnitine plays an essential role in the integration of fat and carbohydrate oxidation in skeletal muscle, which is impaired in obesity and type 2 diabetes.
Objective: The aim of the present study was to investigate the effect of an increase in skeletal muscle total carnitine (TC) content on muscle fuel metabolism.
Design: A 5-h iv infusion of saline (control) or L-carnitine was administered while serum insulin was maintained at a physiologically high concentration during two randomized visits.
Participants: Seven healthy, nonvegetarian young men (body mass index, 26.1 ± 1.6 kg/m2) participated in the present study at the University of Nottingham.
Main Outcome Measures: Skeletal muscle pyruvate dehydrogenase complex (PDC) activity and associated muscle metabolites were measured.
Results: The combination of hypercarnitinemia (600 µmol/liter) and hyperinsulinemia (160 mU/liter) increased muscle TC content by 15% (P < 0.01) and was associated with decreased pyruvate dehydrogenase complex activity (P < 0.05) and muscle lactate content (P < 0.05) by 30 and 40%, respectively, and an overnight increase in muscle glycogen (P < 0.01) and long-chain acyl-coenzyme A content (P < 0.05) by 30 and 40%, respectively, compared with control.
Conclusions: These results suggest that an acute increase in human skeletal muscle TC content results in an inhibition of carbohydrate oxidation in conditions of high carbohydrate availability, possibly due to a carnitine-mediated increase in fat oxidation. These novel findings may have important implications for our understanding of the regulation of muscle fat oxidation, particularly during exercise, when carnitine availability may limit fat oxidation, and in obesity and type 2 diabetes where it is known to be impaired.
This article has been cited by other articles:
![]() |
K. Tsintzas, K. Chokkalingam, K. Jewell, L. Norton, I. A. Macdonald, and D. Constantin-Teodosiu Elevated Free Fatty Acids Attenuate the Insulin-Induced Suppression of PDK4 Gene Expression in Human Skeletal Muscle: Potential Role of Intramuscular Long-Chain Acyl-Coenzyme A J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3967 - 3972. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Stephens, D. Constantin-Teodosiu, and P. L. Greenhaff New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle J. Physiol., June 1, 2007; 581(2): 431 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Stephens, C. E. Evans, D. Constantin-Teodosiu, and P. L. Greenhaff Carbohydrate ingestion augments L-carnitine retention in humans J Appl Physiol, March 1, 2007; 102(3): 1065 - 1070. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |